[ Price : $8.95]
Krieger Scientific CEO Joseph Morwald says a 59% increase in FDA drug Warning Letters in 2025 over 2024 should be seen by industry...[ Price : $8.95]
A Capitol Hill hearing next week examines how FDA can help strengthen the nation's leadership in biomedical innovation.[ Price : $8.95]
Two former FDAers petition the agency to appoint an advisory committee to consider whether anticholinergic drugs are associated wi...[ Price : $8.95]
Former FDAer David Gertler says its time for the agency to resume the unannounced, in-person inspections of drug and medical devic...[ Price : $8.95]
FDA releases the form FDA-483 with eight observations from a reinspection at the Bloomington, IN-based Catalent Indiana sterile dr...[ Price : $8.95]
FDA sends Amphastar Pharmaceuticals subsidiary International Medication Systems a Warning Letter citing current GMP violations at ...[ Price : $8.95]
A Ropes & Gray legal update examines FDA initiatives to shorten drug development timelines and reduce regulatory burdens for spons...[ Price : $8.95]
Four stakeholders express varying opinions on the future direction and existence of the FDA national priority drug voucher program...